Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement. On February 26, 2026 (the “Signing Date”), Hainan Helpson Medical & Biotechnology Co., Ltd (“ Helpson ”), a wholly o
Unregistered Sales of Equity Securities. The information contained in Item 1.01 of this Current Report on Form 8-K in relation to the issuance of the Company’s
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 (1) English Translation of Technology Transfer Agreement, by and between Helpson an